Alnylam Pharmaceuticals
ALNY
#587
Rank
C$49.15 B
Marketcap
$381.09
Share price
0.13%
Change (1 day)
54.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company